Batch ADV-G3-0593 in stock · COA published · Request COA

Collection · 03 — Research Use Only

GLP-3 Retatrutide

Lyophilized Retatrutide triple agonist — HPLC-verified to ≥99% purity, third-party tested, with a batch-matched Certificate of Analysis.

LotADV-G3-0593
$110/ 10 mg vial
COA published · Ships in 24h · Batch-matched documentation travels with the compound
View COA
GLP-3 Retatrutide research laboratory
GLP-3 Retatrutide lyophilized research vial

GLP-3 Retatrutide

LY3437943 · CAS 2381089-83-2 · Triple agonist

In Stock — Lot ADV-G3-0593 · COA published View COA →
$110.00 per 10 mg vial
≥99% HPLCThird-Party TestedCOA Per LotMade in USA

Ships in 24h · Cold-chain guidance included · Batch-matched documentation

CompoundRetatrutide (GLP-3R, LY3437943)
CAS Number2381089-83-2
ClassTriple receptor agonist — GLP-1, GIP, and glucagon receptors
Structure39-AA synthetic peptide with C18 fatty-acid modification
Molecular FormulaC₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight4731.33 Da
FormLyophilized powder, sealed vial
Purity≥99% by HPLC; identity confirmed by MS
Half-Life~6 days (albumin binding)
Storage−20 °C lyophilized; 2–8 °C after reconstitution
StatusInvestigational compound — no approved formulation; Phase 3 TRIUMPH program ongoing

Research Areas

A key reagent for multi-receptor metabolic research: receptor-binding dynamics across GLP-1R/GIPR/GCGR, hepatic lipid-oxidation and thermogenesis models, energy-expenditure studies, and comparative mono/dual/triple agonist pharmacology. Published Phase 2 data (NEJM 2023, Jastreboff et al.) serve as reference literature.

Research Use Only This compound is a chemical supplied strictly for in-vitro laboratory research. It is not a drug, supplement, or cosmetic, is not FDA-evaluated, and is not for human or veterinary consumption. Not for diagnostic or therapeutic use.

Verified on every lot

≥99%
HPLC Purity
MS
Identity Confirmed
Screened
Endotoxins
Screened
Heavy Metals

From quote to bench in days

01

Request quote

Select vial size and submit a quote request — a specialist confirms lot availability.

02

Confirm COA

Review the batch-matched Certificate of Analysis before anything ships.

03

Cold-chain shipment

Orders process in 24h with temperature-controlled handling guidance.

04

Documented arrival

Batch documentation travels with the compound for your lab records.

You May Also Study

Single Agonist In Stock GLP-1 Semaglutide research vial View Compound

GLP-1

Semaglutide · 31-AA analog

$95 / 10 mg≥99% HPLC
Single Agonist In Stock GLP-2 Teduglutide research vial View Compound

GLP-2

Teduglutide · 33-AA analog

$120 / 10 mg≥99% HPLC

Questions, answered

Every lot is analyzed by HPLC for purity (≥99%) with identity confirmed by MS, screened for heavy metals and endotoxins, and released only after independent verification. The batch-matched COA ships with the compound — request it here.

Lyophilized powder in a sealed vial, batch-matched documentation (COA), and cold-chain handling guidance. Nothing more, nothing less.

Orders process within 24 hours. Store lyophilized vials at −20 °C; after reconstitution, keep at 2–8 °C. Protect from light and moisture.

Contact us with your lot number (this page: ADV-G3-0593) and we will reissue the COA within one business day. No lot ships without a published COA.

Retatrutide (LY3437943, C₂₂₁H₃₄₂N₄₆O₆₈, 4731.33 Da) is a 39-AA synthetic peptide with C18 fatty-acid modification spanning GLP-1, GIP, and glucagon receptors — a key reagent for comparative mono/dual/triple agonist pharmacology.

There is no approved formulation; the Phase 3 TRIUMPH program is ongoing and published Phase 2 data (NEJM 2023, Jastreboff et al.) serve as reference literature. Supply is strictly for in-vitro laboratory research — not for human or veterinary use.

Run multi-receptor pharmacology on a verified lot.

Qualified laboratories only. Lot ADV-G3-0593 ships with batch-matched documentation and cold-chain handling guidance.

Questions on this lot? (347) 968-3894 advigrow@gmail.com